Investigative Site — Dallas, Texas

Investigative Site is a clinical research site located in Dallas, Texas, United States 75251.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigative Site has participated in 15 clinical trials with 1 currently active.

Therapeutic areas: Influenza A, Alport Syndrome, Focal Segmental Glomerulosclerosis.

Sponsors: Vir Biotechnology, Inc., River 3 Renal Corp., Trishula Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site?

Investigative Site has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site conducted?

Investigative Site has 15 clinical trials on record, with 1 currently active. Their work covers Influenza A, Alport Syndrome, Focal Segmental Glomerulosclerosis.

Is Investigative Site accredited by Crixeo Clinical Trials?

Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.